MS vs NEPH · P/E 20, $344.27B cap vs P/E 48, rev $14.2M
Morgan Stanley (MS) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
MS currently screens at market cap $344.27B and trailing P/E 19.8. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the MS and NEPH stock pages for the full models.
Not investment advice.